About Sterling Biotech Limited
Data last updated:
Sterling Biotech Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Perfect Day Inc.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L51900MH1985PLC035738. Its GSTIN is 27AABCS1946H1ZC (Maharashtra). The company holds 11 GST registrations, of which 7 are active. It is recorded as listed by MCA, but its shares were delisted from NSE on 03 Mar 2023 · voluntary delisting and from BSE on 03 Mar 2023 · voluntary delisting, and no longer trade on a stock exchange.
The company has an authorised share capital of ₹2,800 Cr and a paid-up capital of ₹643.35 Cr. It was formerly known as Sterling Tea & Indutries Limited and Pluto Exports & Consultants Limited. It is led by directors including Monisha Prabhu Macedo and Vishal Jyotindra Gor.
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹547.82 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹30.23 Cr (net margin 5.5%) and EBITDA of ₹136.68 Cr (EBITDA margin 25%).
The company has about 249 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Sterling Gelatin and Sterling Biotech. As per MCA filings, the company has open charges of ₹684.1 Cr and satisfied charges of ₹21,758 Cr on record. Court records list 263 cases involving the company, including 35 filed by the company and 228 filed against it; 69 cases are pending. The company has 45 deals on record (25 market trades, 16 funding rounds, 3 acquisitions), with disclosed funding of ₹2,766.5 Cr; the latest was in September 2024. Its 6 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Biophore India Pharmaceuticals Private Limited with revenue of ₹457 Cr. The company has 10 MSME Form 1 returns on record between 2014 and 2024, listing 1,202 overdue payments to 106 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sterlingbiotech.in.
Company details
Name history
Sterling Biotech has undergone 2 name changes throughout its history. The company was previously known as Sterling Tea & Indutries Limited, and Pluto Exports & Consultants Limited. The current legal name is Sterling Biotech Limited.
| Company Name | Status |
|---|---|
| Sterling Biotech Limited | Current |
| Sterling Tea & Indutries Limited | Previous |
| Pluto Exports & Consultants Limited | Previous |
CIN history
Sterling Biotech has one previous CIN (Corporate Identification Number): U51900MH1985PTC035738. The current CIN is L51900MH1985PLC035738, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51900MH1985PLC035738 | Current |
| U51900MH1985PTC035738 | Previous |
Contact details
Sterling Biotech Limited's registered office is in Mumbai, Maharashtra. Its website is sterlingbiotech.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address201 – 202 Midas Sahar Plaza, Andheri Kurla Road Andheri East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Sterling Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sterling Biotech operates two associated brands: Sterling Gelatin and Sterling Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer and supplier of fermentation based and synthetic APIs | sterlingbiotech.in | |
| Gelatin manufacturing and supply operations in Gujarat. | sterlinggelatin.com |
Business activity
The main business activity of Sterling Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sterling Biotech Limited, buy the company report.
Financials of Sterling Biotech Limited
FY 2025 filings availableSterling Biotech Limited reported revenue of ₹547.82 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year. EBITDA rose 2% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹547.82 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹136.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sterling Biotech Limited, buy the company report.
Board of directors of Sterling Biotech Limited
Sterling Biotech has 6 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monisha Prabhu Macedo Also directs: Minerva Resolutions LLP, Interise Investment Managers Private Limited, Wood Burning Stoves India Private Limited and 1 more | Nominee Director | 24 Mar 2025 | 1 Years 6 Months | Current |
| Vishal Jyotindra Gor Also directs: Biochem Pharmaceutical Private Limited, Zydus Global Treasury Centre Ifsc Limited, Zydus Strategic Investments Limited and 2 more | Nominee Director | 29 Aug 2024 | 2 Years 1 Months | Current |
| Keyur Anilkumar Parekh Also directs: Zydus Vtec Limited, Zydus Medtech Private Limited | Nominee Director | 29 Aug 2024 | 2 Years 1 Months | Current |
| Alok Kumar Garg Also directs: Visit Health Private Limited | Nominee Director | 29 Aug 2024 | 2 Years 1 Months | Current |
| Aftab Mathur Also directs: Evolutionx Debt Capital Advisors India Private Limited | Nominee Director | 25 Jun 2025 | 1 Years 3 Months | Current |
| Priyadarshan Kumar Singh | Additional Director | 24 Mar 2026 | 0 Years 6 Months | Current |
Peer comparison
Sterling Biotech Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sterling Biotech Limitedthis company | ₹547.82 Cr (FY 2025) | ₹30.23 Cr | 5.5% | 3.0% | 249 | Mumbai, Maharashtra, India |
| Biophore India Pharmaceuticals Private Limited | ₹457 Cr (FY 2025) | 18.0% | Hyderabad, Telangana, India | |||
| S Kant Healthcare Limited | ₹452.24 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Olon Active Pharmaceutical Ingredients India Private Limited | ₹431.21 Cr (FY 2025) | 11.0% | Thane, Maharashtra, India | |||
| Senores Pharmaceuticals Limited | ₹417.51 Cr (FY 2025) | 92.0% | Ahmedabad, Gujarat, India | |||
| Themis Medicare Limited | ₹410.18 Cr (FY 2025) | 6.0% | Vapi, Gujarat, India | |||
| Penam Laboratories Limited | ₹407.63 Cr (FY 2025) | -26.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sterling Biotech Limited, buy the company report.
Auditor
Sterling Biotech Limited is audited by Deloitte Haskins & Sells for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells | FY 2024 | 117365W |
Shareholding
The shareholding of Sterling Biotech Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2017 | FY 2016 | FY 2014 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sterling Biotech Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 2025 | 101161938 | Others | ₹572 Cr | Open | |
| 18 Sep 2025 | 101161944 | Others | ₹95 Cr | Open | |
| 28 Nov 2023 | 100821949 | State Bank of India | ₹2.7 Cr | Open | |
| 19 Oct 2023 | 100803539 | Hdfc Bank Limited | ₹14.4 Cr | Open | |
| 03 Oct 2023 | 100802004 | Others | ₹24 Cr | Satisfied |
To see the full charge records of Sterling Biotech Limited, buy the company report.
Total charge records: 83 View all charges
Deals & funding
Sterling Biotech Limited has 45 deals on record (25 market trades, 16 funding rounds, 3 acquisitions), with disclosed funding of ₹2,766.5 Cr; the latest was in September 2024.
Deals on record (5 of 45)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2024 | Acquisition | ₹84 Cr | Buyer: Zydus Lifesciences Limited Seller: Sterling Biotech Limited |
| Aug 2024 | Acquisition | ₹550 Cr | Buyer: Zydus Animal Health and Investments Limited Seller: Perfect Day Inc |
| Jan 2012 | Market trade | ₹2.25 Cr | Seller: NBN Fintrade Private Limited |
| Jan 2012 | Market trade | ₹24.09 Cr | Buyer: NBN Fintrade Private Limited , Vora Financial Services Private Limited , Blue Peacock Securities Private Limited Seller: NBN Fintrade Private Limited , Vora Financial Services Private Limited , Destimoney Financial Services Private Limited |
| Mar 2008 | Market trade | ₹15.35 Cr | Buyer: Amin Technology Services Private Limited Seller: Soft Star Mercantile Company Pvt. Ltd. |
To see the full deal history of Sterling Biotech Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sterling Biotech Limited has 263 court cases on record: 35 filed by Sterling Biotech, 228 filed against it. 69 cases are pending and 194 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 170 | 160 | 60 |
| High courts | 60 | 42 | 0 |
| NCLAT | 22 | 16 | 9 |
| Supreme Court | 9 | 8 | 0 |
| NCLT | 2 | 2 | 0 |
Cases on record (5 of 263)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against Sterling Healthcare Ltd. Through Resolution Professional Dhiren Shantilal Shah | Pending |
| Bombay High Court | Appeal | Filed by the company against HDFC Bank Ltd | Disposed |
| Bombay High Court | Appeal | Filed by the company against M/S. Manga Capsules Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against Ms. Manga Capsules Ltd. Others and 7 others | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against Ms. Manga Capsules Ltd Others | Disposed |
To see the full case history of Sterling Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sterling Biotech Limited has 10 MSME Form 1 returns on record between 2014 and 2024, listing 1,202 overdue payments to 106 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 106)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Shree Nath Agro Fuel | |||
| an individual supplier | |||
| an individual supplier | |||
| Shakti Enterprise (Dabhasa) |
To see the full MSME payment records of Sterling Biotech Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sterling Biotech Limited has a workforce of 249 employees on its EPFO records as of Mar 27, 2025, across 2 active EPFO establishments.
GST
Sterling Biotech has 11 GST registrations: 7 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCS1946H1ZC | Maharashtra | Active | 01 Jul 2017 |
| 27AABCS1946H2ZB | Maharashtra | Active | 16 Oct 2017 |
| 24AABCS1946H1ZI | Gujarat | Active | 01 Jul 2017 |
| 33AABCS1946H1ZJ | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sterling Biotech Limited, buy the company report.
Recent activity
Sterling Biotech Limited has 32 board changes on record since 1991: 20 appointments and 12 cessations. The latest: Priyadarshan Kumar Singh was appointed as Additional Director on 24 Mar 2026.
200 earlier events are in the company report.
News
Frequently asked questions
Sterling Biotech is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 1985 (41+ years old) and is registered under CIN L51900MH1985PLC035738.
Sterling Biotech has 6 current directors:
- Monisha Prabhu Macedo - Nominee Director
- Vishal Jyotindra Gor - Nominee Director
- Keyur Anilkumar Parekh - Nominee Director
- Alok Kumar Garg - Nominee Director
- Aftab Mathur - Nominee Director
- Priyadarshan Kumar Singh - Additional Director
The latest financial statements of Sterling Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 17 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sterling Biotech is 27AABCS1946H1ZC, registered in Maharashtra. The company has 11 GST registrations in all, of which 7 are active and 4 are cancelled or inactive. Other active GSTINs include 27AABCS1946H2ZB (Maharashtra), 24AABCS1946H1ZI (Gujarat), 33AABCS1946H1ZJ (Tamil Nadu).
The CIN (Corporate Identification Number) of Sterling Biotech is L51900MH1985PLC035738. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sterling Biotech is recorded as a listed company by MCA, but its shares were delisted from NSE on 03 Mar 2023 · voluntary delisting and from BSE on 03 Mar 2023 · voluntary delisting, and no longer trade on a stock exchange.
Sterling Biotech has 263 court cases on record: 35 filed by the company and 228 filed against it. 69 are pending. Most are in the district courts.
Sterling Biotech was incorporated on 23 March 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
Sterling Biotech has 45 deals on record (25 market trades, 16 funding rounds, 3 acquisitions), with disclosed funding of ₹2,766.5 Cr; the latest was in September 2024.
The peers of Sterling Biotech by revenue are Biophore India Pharmaceuticals Private Limited, S Kant Healthcare Limited, Olon Active Pharmaceutical Ingredients India Private Limited, Senores Pharmaceuticals Limited, Themis Medicare Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Priyadarshan Kumar Singh was appointed as Additional Director on 24 Mar 2026. Anil Shantilal Inani was appointed as CFO on 16 Jul 2025. Aftab Mathur was appointed as Nominee Director on 25 Jun 2025. Sterling Biotech has 32 board changes on record in total.
Sterling Biotech has 10 MSME Form 1 returns on record between 2014 and 2024, listing 1,202 overdue payments to 106 micro and small suppliers. The latest return was filed on 30 Apr 2024.